MILLENNIUM MANAGEMENT LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2022$15,000
-34.8%
23,683
+4.7%
0.00%–
Q2 2022$23,000
-39.5%
22,615
-17.7%
0.00%–
Q1 2022$38,000
-57.8%
27,492
+74.9%
0.00%–
Q3 2021$90,000–15,722–0.00%–
 Download
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 72,452$44,0000.00%
HighMark Wealth Management LLC 6,966$4,0000.00%
UBS Group AG 26$00.00%
WELLS FARGO & COMPANY/MN 46$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 47,178$28,0000.00%
STATE STREET CORP 14,455$9,0000.00%
MILLENNIUM MANAGEMENT LLC 23,683$15,0000.00%
MORGAN STANLEY 10,611$7,0000.00%
BlackRock Inc. 74,192$45,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders